2m 2m 2m 2m 2m 2m 2m
GOSSAMER BIO (GOSS)
NASDAQ
$9.44-$0.35 (-3.58%)
Price as of Oct 22, 2026 7:30 PM EDT- $59.9MMarket Cap
- -94.46%1-Year Change
- BiotechnologyIndustry
GOSSAMER BIO (GOSS)
$9.44-$0.35 (-3.58%)
GOSS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.79 | ||
Change | +$0.21 (+2.19%) | ||
Open | $9.50 | ||
High | $10.39 | ||
Low | $9.50 | ||
Previous Close | $9.58 | ||
Volume | 218,965 | ||
30-Day Average Volume | 294,884 | ||
1-Week Change | 9.94% | ||
1-Month Change | -13.21% | ||
1-Year Change | -94.46% | ||
3-Year Change | -77.41% | ||
5-Year Change | -99.03% | ||
Fundamentals | |||
Shares Outstanding | 6.1M | ||
Total Assets | $76.9M | ||
Market Cap | $59.9M | ||
Enterprise Value | $110.0M | ||
Period: QTR TTM FY | |||
Revenue | $9.2M | ||
Net Income | $16.9M | ||
Free Cash Flow | -$39.4M | ||
EBIT | $19.6M | ||
EBITDA | $19.6M | ||
Net Working Capital | -$65.1M | ||
EPS | -$6.40 | ||
Enterprise Value/EBITDA | 6 | ||
Enterprise Value/Revenue | 12 | ||
P/B | -1 | ||
P/E | -2 | ||
PEG | -0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 80 | ||
Last Split Date | 09/11/2026 | ||
Earnings & Revenue